Heidt, Sebastiaan <br/><br/>
Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to nonsensitized patients.  [electronic resource] 

 -  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons  10 2019 
 - 2926-2933 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-6143 
<br/><br/><label>Standard No.: </label>10.1111/ajt.15486  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Female<br/>Follow-Up Studies<br/>Graft Rejection--diagnosis<br/>Graft Survival--immunology<br/>HLA Antigens--chemistry<br/>Histocompatibility--immunology<br/>Histocompatibility Testing<br/>Humans<br/>Immunization--methods<br/>Isoantibodies--adverse effects<br/>Kidney Failure, Chronic--immunology<br/>Kidney Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Patient Selection<br/>Prognosis<br/>Risk Factors<br/>Tissue Donors--supply & distribution<br/>Tissue and Organ Procurement--methods<br/>Transplantation Immunology